Pure Global AI
NCT06299488Completed

Combined Effects of Prunus Cerasus and Apocynum Venetum On Sleep and Anxiety in Adults With Insomnia

Combined Effects of Prunus Cerasus (Montmorency Tart Cherry) and Apocynum Venetum (Venetron®) On Sleep and Anxiety in Adults With Insomnia
Lakshmi Nutraceuticals LLCClinicalTrials.govother
Verified
Study focus
Disease/Condition
Insomnia
Drug/Device/Intervention
Sip2Sleep: Montmorency Cherry and Apocynum Venetum
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Lakshmi Nutraceuticals LLC
Location
West Hollywood, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 05, 2023
End date
Jul 01, 2023
Enrollment
77 participants
Primary outcome

Subjective Sleep Quality

Summary

Lay Summary: This study is about the effect of using a unique formula called Sip2Sleep®, a
 product currently available on the market which is a combination of montmorency tart cherry
 extract and Venetron® (Apocynum venetum leaf extract) on sleep. The purpose of this study is
 to evaluate the effects of taking this combination product on various aspects of sleep. This
 study is being conducted by People Science, and is sponsored by Lakshmi Nutraceuticals, LLC.
 The information we gather will help inform how people may use Sip2Sleep® to affect the
 quality of sleep.
 
 Participants in this study will complete a number of surveys about their difficulties falling
 asleep and staying asleep (insomnia), their energy level during the day and health status
 regarding their quality of sleep.
 
 There are no major risks associated with this study.

ICD-10 classifications
Nonorganic insomniaDisorders of initiating and maintaining sleep [insomnias]Sleep disordersSleep disorder, unspecifiedOther sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06299488
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06299488 through Pure Global AI's free database. This phase not specified trial is sponsored by Lakshmi Nutraceuticals LLC and is currently Completed. The study focuses on Insomnia. Target enrollment is 77 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.